Pfizer Inc.

  • Retailers claim Pfizer kept generic drug off the market

    Pharmaceutical giant Pfizer Inc. was accused by Walgreen Co. and several other prescription drug retailers of violating U.S. antitrust law. The retailers claim Pfizer’s Wyeth unit and Teva Pharmaceutical Industries Ltd illegally kept a generic version of popular antidepressant Effexor XR off the market.

  • China cracks down on fake sex-pill makers

    Chinese counterfeiters are scurrying for cover as the government criminalized the manufacture of fake medicines earlier this year. Police have busted more than 1,400 illegal drug dens and locked up eight sex-pill makers in the past month in an effort to deflate an estimated $3 billion worth of pseudo drugs.

  • Glaxo agrees to pay $3 billion to settle marketing probes

    Today GlaxoSmithKline (GSK), the U.K.’s biggest drug company, announced that it has agreed to pay the U.S. government $3 billion to settle several criminal and civil probes related to its sales and marketing practices.

  • Several drug makers win in product liability litigation

    According to an analysis reported by Reuters, a series of wins for pharmaceutical companies defending themselves in product liability litigation may be good news for corporate defendants in general.

Advertisement. Closing in 15 seconds.